Velarion Records
Free. Unsubscribe any time.

Vaxcyte, Inc. (PCVX)

Vaxcyte, Inc. filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 79 transactions and 207,375 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Vaxcyte, Inc. 79

Adoption dates in Vaxcyte, Inc. 9

Results prints in Vaxcyte, Inc. 0

Trades before a print in Vaxcyte, Inc. 0

Interval to Vaxcyte, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Vaxcyte, Inc. states

Filing text: “10b5-1 trading plan adopted March 4, 2026”

Sources: SEC EDGAR full-text search and the SEC submissions API.